Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

STOREBRAND BANK ASA – SALE AND BUYBACK OF BOND

STOREBRAND BANK ASA – SALE AND BUYBACK OF BOND Storebrand Bank ASA has sold NOK 500 million in bond - STORK 14 - ISIN NO0010813959 – utstedet av Storebrand Boligkreditt AS. The bond maturity date is 20.06.2023. Storebrand Bank ASA has bought NOK 350  million of bond - STORK 11  - ISIN  NO0010736903 – issued by Storebrand Boligkreditt AS. The bond maturity date is 17.06.2020. Storebrand Boligkredit AS  has bought back NOK 120  million of bond - STORK 06  - ISIN  NO0010548373. The bond maturity date is 28.10.2019. Outstanding volume after the buyback are NOK 833 million. Contact

Invitation to conference call in connection with the Interim report for the second quarter of 2019

SaltX Technology Holding invites to conference call/online presentation August 23, 2019, at 10:00 CEST (Swedish presentation) and at 11:00 CEST (English presentation). CEO Carl-Johan Linér presents the report together with Harald Bauer, CFO. Thereafter, the opportunity is given to ask questions.The quarterly report 2 2019 will be published on August 23 at about 08:00.How to participate: 10:00 CEST (Swedish presentation)  - Via Computer: https://zoom.us/j/327227675- By phone: +46 (0) 8 4468 2488- Enter Meeting ID: 327 227 675 11:00 CEST (English presentation)  - Via

Subscription for shares in the subsequent offering by primary insiders

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Reference is made to the subsequent offering (the “Subsequent Offering”) in Norwegian Energy Company ASA (the “Company”) as previously announced, latest on 12 August 2019. Riulf Rustad, chairman of the board in the Company, has today through his wholly

Etteplan Oyj - Managers' transactions

Etteplan Oyj, Stock Exchange Release, August 16, 2019, at 4:00 p.m. Etteplan Oyj - Managers' Transactions____________________________________________Person subject to the notification requirementName: Saarinen, Leena MariaPosition: Member of the Board/Deputy memberIssuer: Etteplan OyjLEI: 7437006I5533R06JU690Notification type: INITIAL NOTIFICATIONReference number: 7437006I5533R06JU690_20190816150832_2____________________________________________Transaction date: 2019-08-14Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI0009008650Nature of the

Making steel strong – the inside story

The secret to making steel strong involves controlling a number of critical factors – such as cooling, microstructure and chemical position.To make our steel strong, Ovako takes precise control of three key factors: · How the steel is cooled from its molten state · Its microstructure – the very small scale structure seen under a microscope · Its chemical composition – both the carbon content and other alloying elements Steel consists mainly of the element Iron (Fe). In its molten or liquid state, at temperatures above 1,500 degrees Celsius, the iron atoms are able to move

Read original

Bambuser AB (publ) publishes H1 2019

Bambuser's interim report for 2019 has now been published. The report can be found at www.bambuser.com/ir.STRENGTHENED MANAGEMENT TEAM AND FOCUS ON NEW RETAIL LIVE VIDEO January – June 2019 ·Net sales amounted to 1,643 KSEK (2,317)  ·Total income amounted to 1,762 KSEK (2,746)  ·EBIT was -9,683 KSEK (-10,803)  ·Net income was -9,794 KSEK (-10,935) ·Earnings per share of -0.35 SEK (-1.06)  ·Cash flow from operating activities was -10,033 KSEK (-10,850)  ·Cash at end of period was 8,028 KSEK (16,273) For environmental and cost reasons,

PolarCool AB (publ): additional data from the pilot study with SHL and HockeyAllsvenskan show further improved results from the concussion study with PolarCap® System

In collaboration with the Swedish Hockey League (SHL) and HockeyAllsvenskan, PolarCool conducted a study during the past three seasons, wherein PolarCap® System has been evaluated for the treatment of concussion. A total of 12 teams participated in the study; the intervention group has used the PolarCap® System and the control group has consisted of players who have not received the treatment. The purpose of the clinical study has been to measure symptom relief, in order to examine how quickly the player progresses through a mandatory rehab program until return to play. The program is a

Elkem ASA acquires Basel Chemie

Oslo, 16 August, 2019: Elkem ASA acquires Basel Chemie, a Korean producer of specialty silicone gels for cosmetics and water repellents for the construction industry. The acquisition gives Elkem access to leading technology in attractive end-user silicone segments and provides a solid platform for further development and growth. Basel Chemie was founded in 1999 and has a state-of-the-art plant near Gunsan and a new research and development and office centre in Seoul. The company has 32 employees and had an annual turnover of USD 7.7 million in 2018 and an average EBITDA margin of 28%

Novel findings explain indirect regulation of glucose homeostasis

The hormone secreting part of the pancreas, the islets of Langerhans, has a unique cyto-architecture that allows functional interrelationships between the different cell types. Somatostatin is secreted by the delta cell and is an effective inhibitor of the insulin secreting beta cell and the glucagon secreting alpha cell. According to a novel study from Sweden’s Karolinska Instiutet, published in the journal Nature Communications, the delta cell can thereby indirectly affect glucose homeostasis in health and disease.Our results provide important insight into the activity of the delta cell

Purchase of subscription rights in the subsequent offering by primary insiders

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Reference is made to the subsequent offering (“Subsequent Offering”) in Norwegian Energy Company ASA (the “Company”) as previously announced, latest on 12 August 2019. Frederik Rustad, managing director of the Company, has today (through wholly owned

ASETEK – Mandatory Notification of Trade: Chairman Purchases Shares

16 August 2019 – Chairman of the Board of Directors and primary insider of Asetek A/S Jukka Pertola has on Thursday, August 15, 2019 purchased 12 500 shares in the open market at an average price of NOK 19,96 per share. Following the transaction, Jukka Pertola owns 12 500 Asetek shares. About Asetek Asetek is the global leader in liquid cooling solutions for gaming and enthusiast PCs, data centers and servers. Founded in 2000, Asetek is headquartered in Denmark and has operations in California, Texas, China and Taiwan. Asetek is listed on the Oslo Stock Exchange (ASETEK.OL). For

AS Elektrisk wins installation contract with HENT

Instalco’s Norwegian subsidiary, AS Elektrisk, has been engaged for electrical installation work associated with construction of a new retirement home in Hurum, near the city of Drammen in Norway. The client is the Norwegian construction firm, HENT, and the order value for AS Elektrisk is approximately SEK 40 million.The new retirement home (approximately 11,000 sq. m.) will be built in Hurum, which is near Drammen, Norway. The new retirement home will be able to accommodate 110 residents, providing them with care, physical fitness, rehabilitation, daytime activities and a variety of other

INTERIM REPORT Period from January 2019 to June 2019 Peptonic Medical AB (publ) org nr 556776-3064 (www.aktietorget.se ticker: PMED)

2019 FIRST QUARTER (Apr-Jun) · Net sales of products KSEK 1,011 (0) · Gross profit KSEK 768 (0), Gross margin 76% (0%) · Operating loss KSEK -5,102 (-3,563)  · Loss per share SEK -0.06 (-0.04) 2019 FIRST HALF YEAR (Jan-Jun) · Net sales of products KSEK 2,481 (0) · Gross profit KSEK 1,570 (0), Gross margin 63% (0%) · Operating loss KSEK -8,287 (-6,385)  · Loss per share SEK -0.09 (-0.07)From the CEO First half of the year has been very busy and successful. Early in the year, Apoteket AB decided to carry VagiVital in 30 of its largest retail shops and on-

Bioservo signs another strategic distribution agreement for selling the all-new Ironhand® in the US

Bioservo signs another strategic distribution agreement for selling the all-new Ironhand® in the US Bioservo Technologies AB (publ) (Nasdaq First North: BIOS) has entered a distribution agreement for selling the all-new Ironhand® with Rhino Assembly Ltd. for the US market. Rhino Assembly’s mission is to identify and deliver the world’s most innovative assembly solutions reflective of Industry 4.0 and beyond to their customers with focus on building better quality product while maintaining a safe environment for their workers. Rhino Assembly is a well-known partner to the local automotive

YIT has repaid its EUR 50 million pension loan

YIT Corporation                    Investor news                       August 16, 2019 at 10:30 a.m.YIT has on August 15, 2019 repaid its EUR 50 million pension loan on the maturity date of the loan. The repayment was financed with liquid funds and commercial papers. This repayment is part of the integration activities with the aim to reduce financial costs following the merger of YIT and Lemminkäinen. For further information, please contact:Hanna Jaakkola, Vice President, Investor Relations, YIT Corporation, tel. +358 40 5666 070, hanna.jaakkola@yit.fi YIT CORPORATION Hanna

Nel ASA: Closes agreements related to Everfuel and signs sales and service agreement

(Oslo, 16 August 2019) Nel ASA (OSE: NEL) announced today the closing of the agreements related to the ownership structure in Everfuel Europe A/S (Everfuel), including the signing of an exclusive equipment sales and service agreement. Everfuel will provide a complete offering of hydrogen fuel to heavy duty customers such as city buses (reference is made to the announcement 3 June 2019). As an owner/operator of electrolyzers and fueling stations, Everfuel will vertical integrate the hydrogen value chain to reduce the total cost for the end customer. As an example, bus operators in Europe

Episurf Medical reaches new milestones in its patient population

Episurf Medical (Nasdaq: EPIS B) today announces that the company has reached new milestones in its patient population as more than 100 Episealer® patients now have had their knee implants for more than 3 years, and more than 200 patients have had the implants for more than 2 years. A few months ago, the company announced that 500 patients had been treated with the Episealer® knee implant. The company now reports increasing patient populations in the important 2 and 3-year follow-up periods. A significant part of the patients treated, especially among the first patients which were

Subscription for shares in the subsequent offering by primary insiders

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Reference is made to the subsequent offering (the “Subsequent Offering”) in Norwegian Energy Company ASA (the “Company”) as previously announced, latest on 12 August 2019. Lars Purlund, board member of the Company, has on 15 August 2019 subscribed for 1,982

NextCell Pharma files another patent application

NextCell Pharma AB ("NextCell") today announces that they have filed a new patent application to the Swedish Patent and Registration Office. The patent relates to the Company's proprietary selection algorithm, now with extended and tailored analyses for diseases and conditions affecting the central nervous system.The application was submitted to the Swedish Patent and Registration Agency on August 15 and is formulated to cover the general production of all types of mesenchymal stem cell products derived from multiple donors and cells selected by the selection algorithm. Furthermore, the

XMReality AB (publ), Interim Report, April–June 2019

XMReality delivered sales growth of 37 percent for the second quarter of the year compared with the previous year and strong improvement in the gross margin to 87 (59) percent. Change was successfully implemented during the period in line with its strategy to increase subscription revenue.The quarter: April–June 2019 · Net sales increased by 37 percent to SEK 2,993 thousand (2,186) · Costs totaled SEK -11,997 thousand (-11,620) · The net loss was SEK -7,585 thousand (-7 817). · Net cash used in the period was SEK -4,233 thousand (-8,333) and the equity/assets ratio at the end

INVISIO Interim Report January–June 2019: The strongest quarter so far

CEO comment”Order intake, sales and results in the second quarter are the highest so far and are largely attributable to the order worth SEK 111 million from the new customer USSOCOM (United States Special Operations Command). INVISIO also received a strategic break­through order from the German police, which is an important reference for addressing future customers in the police and security market. After the end of the period, the U.S. Marine Corps selected INVISIO for their Hearing Enhancement Program and placed an initial order of SEK 43 million. The positive performance, along with a

Interim report January-June 2019

Total return on the Bure share was 47.9 per centJanuary – June 2019 · Net asset value was SEK 153.5 per share compared to SEK 137.1 at the beginning of the year, which corresponds to an increase of 12.0 per cent. · Bure’s net asset value was SEK 10,591M compared to SEK 9,454M at the beginning of the year. · Total return on the Bure share was 47.9 per cent compared to the SIX Return Index that increased 20.7 per cent. · Consolidated profit after tax amounted to SEK 1,273M (1,132). Earnings per share amounted to SEK 18.46 (16.33). Second quarter 2019 · Net asset value

Tethys Oil’s holding of own shares has temporarily decreased below 5 percent

Tethys Oil AB (publ) (“Tethys Oil”) has, on 15 August 2019, entered into a share loan agreement (as the lender) regarding own shares with an investment bank. The purpose of the share loan is to facilitate the exercise of Tethys Oil’s long-term incentive programme of warrants from 2016. Following the entering of the share loan agreement, the number of own shares held by Tethys Oil has been reduced by 416,500 and the total number of own shares held amounts to 1,537,663. The holding corresponds to 4.28 percent of the total number of shares and votes in Tethys Oil (based on 35,896,310 shares

Endomines’ AB Half-year interim report for 2019: Rights issue successfully completed – production ramp-up at Friday commenced

Endomines AB, Stock Exchange Release 16 August 2019 at 08:30 CESTH1 2019 (vs. H1 2018)Operational highlights · Construction of the Mill was ongoing and developmental drifting at the Friday Mine was the focus for Q2 · Construction of the Tailings pond at the mill was also a large focus of time and materials · There was no gold concentrate production in Q2 2019 · LTIFR 11 (9) Financial highlights · Revenue was 3.5 MSEK (71.5) · EBITDA was -20.8 MSEK (0.0) · Total cash flow was -13.2 MSEK (71.6) · Earnings per share was -0.85 SEK (-0.10) Significant

There are no items matching the current filter
There are no more items matching the current filter
Back to top